CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Accumulated Other Comprehensive (Loss) Gain	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		47,829
Beginning balance at Dec. 31, 2023	$ 225,952	$ 629,229	$ (100)	$ (403,177)
Increase (Decrease) in Shareholders' Equity
Net income (loss)	(3,862)			(3,862)
Stock-based compensation expense	9,834	$ 9,834
Stock option exercises (in shares)		487
Stock option exercises	6,779	$ 6,779
Shares issued under the Employee Stock Purchase Plan (in shares)		9
Shares issued under the Employee Stock Purchase Plan	247	$ 247
Issuance of stock for restricted stock unit vesting (in shares)		265
Restricted stock withheld for employee tax remittance (in shares)		(101)
Restricted stock withheld for employee tax remittance	(4,909)	$ (4,909)
Unrealized gain (loss) on investments	(145)		(145)
Ending balance (in shares) at Mar. 31, 2024		48,489
Ending balance at Mar. 31, 2024	233,896	$ 641,180	(245)	(407,039)
Beginning balance (in shares) at Dec. 31, 2023		47,829
Beginning balance at Dec. 31, 2023	225,952	$ 629,229	(100)	(403,177)
Increase (Decrease) in Shareholders' Equity
Net income (loss)	(9,445)
Unrealized gain (loss) on investments	459
Ending balance (in shares) at Sep. 30, 2024		49,265
Ending balance at Sep. 30, 2024	257,472	$ 669,735	359	(412,622)
Beginning balance (in shares) at Mar. 31, 2024		48,489
Beginning balance at Mar. 31, 2024	233,896	$ 641,180	(245)	(407,039)
Increase (Decrease) in Shareholders' Equity
Net income (loss)	(4,682)			(4,682)
Stock-based compensation expense	9,520	$ 9,520
Stock option exercises (in shares)		329
Stock option exercises	4,020	$ 4,020
Shares issued under the Employee Stock Purchase Plan (in shares)		14
Shares issued under the Employee Stock Purchase Plan	414	$ 414
Issuance of stock for restricted stock unit vesting (in shares)		34
Restricted stock withheld for employee tax remittance (in shares)		(4)
Restricted stock withheld for employee tax remittance	(163)	$ (163)
Unrealized gain (loss) on investments	(28)		(28)
Ending balance (in shares) at Jun. 30, 2024		48,862
Ending balance at Jun. 30, 2024	242,977	$ 654,971	(273)	(411,721)
Increase (Decrease) in Shareholders' Equity
Net income (loss)	(901)			(901)
Stock-based compensation expense	9,224	$ 9,224
Stock option exercises (in shares)		382
Stock option exercises	5,442	$ 5,442
Shares issued under the Employee Stock Purchase Plan (in shares)		9
Shares issued under the Employee Stock Purchase Plan	353	$ 353
Issuance of stock for restricted stock unit vesting (in shares)		16
Restricted stock withheld for employee tax remittance (in shares)		(4)
Restricted stock withheld for employee tax remittance	(255)	$ (255)
Unrealized gain (loss) on investments	632		632
Ending balance (in shares) at Sep. 30, 2024		49,265
Ending balance at Sep. 30, 2024	$ 257,472	$ 669,735	359	(412,622)
Beginning balance (in shares) at Dec. 31, 2024	49,628	49,628
Beginning balance at Dec. 31, 2024	$ 291,967	$ 684,778	4	(392,815)
Increase (Decrease) in Shareholders' Equity
Net income (loss)	(11,246)			(11,246)
Stock-based compensation expense	11,505	$ 11,505
Stock option exercises (in shares)		398
Stock option exercises	9,158	$ 9,158
Shares issued under the Employee Stock Purchase Plan (in shares)		7
Shares issued under the Employee Stock Purchase Plan	251	$ 251
Issuance of stock for restricted stock unit vesting (in shares)		332
Restricted stock withheld for employee tax remittance (in shares)		(113)
Restricted stock withheld for employee tax remittance	(6,280)	$ (6,280)
Unrealized gain (loss) on investments	132		132
Ending balance (in shares) at Mar. 31, 2025		50,252
Ending balance at Mar. 31, 2025	$ 295,487	$ 699,412	136	(404,061)
Beginning balance (in shares) at Dec. 31, 2024	49,628	49,628
Beginning balance at Dec. 31, 2024	$ 291,967	$ 684,778	4	(392,815)
Increase (Decrease) in Shareholders' Equity
Net income (loss)	(6,725)
Unrealized gain (loss) on investments	$ 254
Ending balance (in shares) at Sep. 30, 2025	50,550	50,550
Ending balance at Sep. 30, 2025	$ 321,858	$ 721,140	258	(399,540)
Beginning balance (in shares) at Mar. 31, 2025		50,252
Beginning balance at Mar. 31, 2025	295,487	$ 699,412	136	(404,061)
Increase (Decrease) in Shareholders' Equity
Net income (loss)	(553)			(553)
Stock-based compensation expense	10,140	$ 10,140
Stock option exercises (in shares)		147
Stock option exercises	1,320	$ 1,320
Shares issued under the Employee Stock Purchase Plan (in shares)		13
Shares issued under the Employee Stock Purchase Plan	468	$ 468
Issuance of stock for restricted stock unit vesting (in shares)		33
Restricted stock withheld for employee tax remittance (in shares)		(4)
Restricted stock withheld for employee tax remittance	(100)	$ (100)
Unrealized gain (loss) on investments	47		47
Ending balance (in shares) at Jun. 30, 2025		50,441
Ending balance at Jun. 30, 2025	306,809	$ 711,240	183	(404,614)
Increase (Decrease) in Shareholders' Equity
Net income (loss)	5,074			5,074
Stock-based compensation expense	8,699	$ 8,699
Stock option exercises (in shares)		84
Stock option exercises	1,097	$ 1,097
Shares issued under the Employee Stock Purchase Plan (in shares)		10
Shares issued under the Employee Stock Purchase Plan	385	$ 385
Issuance of stock for restricted stock unit vesting (in shares)		22
Restricted stock withheld for employee tax remittance (in shares)		(7)
Restricted stock withheld for employee tax remittance	(281)	$ (281)
Unrealized gain (loss) on investments	$ 75		75
Ending balance (in shares) at Sep. 30, 2025	50,550	50,550
Ending balance at Sep. 30, 2025	$ 321,858	$ 721,140	$ 258	$ (399,540)